Table 4.
Mobius calculated patient dose vs. AcurosXB for first 36 intensity‐modulated casesa post‐clinical implementation
| Target mean dose percent difference (%) | Target D95% percent difference (%) | 3D global gamma pass rate (%) | Target gamma pass rate (%) | Dose calculation point percent difference (%) | |
|---|---|---|---|---|---|
| Average | 0.0b | −2.0b | 99.2c | 96.5c | 1.8 |
| Max | 2.4 | 4.6 | 100.0 | 100.0 | 4.7 |
| Min | −4.8 | −10.0 | 96.7 | 69.0 | −1.6 |
| Standard deviation | 1.6 | 2.4 | 0.8 | 5.6 | 1.3 |
a
Analyzed cases include first 36 IMRT and VMAT plans treated post‐implementation of the Mobius system in our clinic.
b
A positive percent difference indicates that the Mobius calculated dose is higher than AcurosXB.
c
3D global gamma and target gamma were calculated with a 5%, 2 mm criteria.